文献

J-GLOBAL ID：201002232380926602   整理番号：10A0722800

組み換えヒトエリスロポイエチンの単回静脈内投与は急性心筋梗塞患者に対する有望な治療である-EPO/AMI-1研究のランダム化比較パイロット試験-

Single-Dose Intravenous Administration of Recombinant Human Erythropoietin Is a Promising Treatment for Patients With Acute Myocardial Infarction - Randomized Controlled Pilot Trial of EPO/AMI-1 Study -

著者 (12件)： OZAWA Takuya (First Dep. of Internal Medicine, Niigata Univ. Medical and Dental Hospital) ,  TOBA Ken (First Dep. of Internal Medicine, Niigata Univ. Medical and Dental Hospital) ,  SUZUKI Hiroshi (Div. of Cardiology, Dep. of Internal Medicine, Showa Univ. Fujigaoka Hospital) ,  KATO Kiminori (First Dep. of Internal Medicine, Niigata Univ. Medical and Dental Hospital) ,  ISO Yoshitaka (Div. of Cardiology, Dep. of Internal Medicine, Showa Univ. Fujigaoka Hospital) ,  AKUTSU Yasushi (Div. of Cardiology, Dep. of Medicine, Showa Univ. School of Medicine) ,  KOBAYASHI Youichi (Div. of Cardiology, Dep. of Medicine, Showa Univ. School of Medicine) ,  TAKEYAMA Youichi (Div. of Cardiology, Dep. of Internal Medicine, Showa Univ. Fujigaoka Hospital) ,  KOBAYASHI Naohiko (Dep. of Hypertension and Cardiorenal Medicine, Dokkyo Univ. School of Medicine) ,  YOSHIMURA Norihiko (Div. of Radiation Oncology, Niigata Univ. Medical and Dental Hospital) ,  AKAZAWA Kohei (Div. of Medical Informatics, Niigata Univ. Medical and Dental Hospital) ,  AIZAWA Yoshifusa (First Dep. of Internal Medicine, Niigata Univ. Medical and Dental Hospital)
資料名： Circulation Journal  (Circulation Journal)
巻： 74  号： 7  ページ： 1415-1423 (J-STAGE)  発行年： 2010年 
JST資料番号： F0908A  ISSN： 1346-9843  資料種別： 逐次刊行物 (A)
記事区分： 原著論文  発行国： 日本 (JPN)  言語： 英語 (EN)

抄録/ポイント： 背景。エリスロポイエチン(EPO)は心筋に及ぼす抗アポトーシ...

シソーラス用語： *エリスロポイエチン ,...
準シソーラス用語： LVEF ,...

ログイン（無料）して見る     続きはJDreamIII（有料）にて  {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=10A0722800&from=J-GLOBAL&jstjournalNo=F0908A") }}

分類 (2件)： 循環系疾患の薬物療法  (GJ05020M) ,  心臓作用薬の臨床への応用  (GW07030Y)

引用文献 (27件)：

• 1. Shiga T, Hagiwara N, Ogawa H, Takagi A, Nagashima M, Yamauchi T, et al; Heart Institute of Japan Acute Myocardial Infarction-II (HIJAMI-II) Investigators. Sudden cardiac death and left ventricular ejection fraction during long-term follow-up after acute myocardial infarction in the primary percutaneous coronary intervention era: Results from the HIJAMI-II registry. Heart 2009; 95: 216-220.
• 2. Doughty RN, Whalley GA, Walsh HA, Gamble GD, López-Sendón J, Sharpe N; CAPRICORN Echo Substudy Investigators. Effects of carvedilol on left ventricular remodeling after acute myocardial infarction: The CAPRICORN Echo Substudy. Circulation 2004; 109: 201-206.
• 3. Sharpe N, Smith H, Murphy J, Greaves S, Hart H, Gamble G. Early prevention of left ventricular dysfunction after myocardial infarction with angiotensin-converting enzyme inhibition. Lancet 1991; 337: 872-876.
• 4. Downey JM, Cohen MV. Why do we still not have cardioprotective drugs? Circ J 2009; 73: 1171-1177.
• 5. Sterin-Borda L, Barceló AC, Bozzini CE. Erythropoietin improves cardiac contractility in post-hypoxic mice. Br J Haematol 2003; 121: 180-186.

タイトルに関連する用語 (10件)： 組み換え ,  静脈内投与 ,  急性心筋梗塞 ,  患者 ,  治療 ,  EPO ,  AMI ,  研究 ,  ランダム化 ,  パイロット試験